Category Archive

“Trans kids didn’t exist until we created them” is blunt phrasing, but the mechanism underneath it is real: kids don’t merely reveal identities; they adopt the identity-models a culture supplies and rewards. Adolescence is a meaning-factory. Pain looks for an explanation. Alienation looks for a tribe. If adults and institutions elevate one interpretive story for distress and then attach moral prestige, protection-from-questioning, and instant community to that story we should expect more kids to step into it. Not because every child is “lying,” but because this is how social scripts spread: they simplify suffering, convert it into status, and offer belonging on demand.

Proponents will tell a cleaner story. They claim “trans kids have always existed” and we’re simply seeing higher visibility in a less stigmatizing age. They claim affirmation is harm reduction. They claim the clinical pathway is cautious, selective, and evidence-informed. And they claim the “social contagion” frame is just a pretext to dismiss real dysphoria. That’s the best version of their public narrative: visibility + safety + compassion + careful medicine. The problem is that this narrative asks society to treat disputed assumptions as settled truth and then to treat moral confidence as a substitute for evidence – precisely in the domain where evidence must be strongest: irreversible interventions for minors.

That’s where the ideology runs aground. The evidence base for pediatric medical transition—especially puberty suppression—has repeatedly been assessed as weak and low-certainty. The York-led systematic review published in Archives of Disease in Childhood concluded there is a lack of high-quality research on puberty suppression in adolescents with gender dysphoria/incongruence, and that no firm conclusions can be drawn about impacts on dysphoria or mental/psychosocial outcomes. A 2025 systematic review in the same journal similarly characterized the best available evidence on puberty blockers’ effects as mostly very low certainty. This isn’t a minor academic quibble. It’s the difference between “we have strong reasons to believe this helps, on balance” and “we cannot be confident what this does to developing bodies and minds.” When the confidence level is that low, the ethical default is not acceleration; it’s restraint.

And restraint is exactly what some public health systems have moved toward—because the claims didn’t cash out in robust evidence. In the UK, the NHS stopped routine prescribing of puberty blockers for under-18s and restricted them to research context, and the government moved to make restrictions indefinite after expert advice citing insufficient evidence of safety. NHS England’s Cass implementation materials also frame puberty blockers as part of a research program with long-term follow-up, alongside evaluation of psychosocial interventions. That is not what “settled science” looks like. That is what a field looks like when it is finally admitting—late—that it has been making high-stakes moves on thin ice.

Now zoom out from the clinic to the culture, because this is the part people keep refusing to say out loud: the social environment is not neutral. Once schools, media, and professional bodies moralize one framework (“affirmation is care”) and stigmatize alternatives (“questioning is harm”), you get a one-way ratchet. A child declares an identity; the adults are trained that the declaration must be treated as authoritative; “exploration” becomes suspect if it doesn’t begin with affirmation; and any friction is rebranded as abuse. That moral framing isn’t compassion—it’s epistemic closure. And epistemic closure is exactly how you end up routing heterogeneous adolescent distress into a single explanatory funnel.

Because the presenting population isn’t one thing. It’s a mix: anxiety, depression, trauma, obsessive traits, social contagion dynamics, autism-spectrum features, sexual discomfort, body dysmorphia, internalized homophobia, loneliness, and the general misery of puberty in a screen-soaked status economy. Give that mix one glamorous story with institutional backing, and you will pull more children into it. You will also make it harder for them to exit, because the identity becomes socially defended and medically reinforced. Once irreversible steps begin, doubt becomes expensive. Regret becomes unspeakable. The “care model” becomes self-protecting: the deeper you go, the harder it is to admit the initial certainty was misplaced.

This is why I don’t treat “gender-affirming care” as a neutral phrase. It’s marketing language for a clinical posture that—too often—front-loads conclusion and back-loads caution. Real care for minors under uncertainty looks boring: slow assessment, serious differential diagnosis, treatment of comorbidities, family stability, and time. Real care doesn’t require anyone to be cruel. It requires adults to resist the temptation to turn a child’s distress into an adult moral performance. It requires institutions to stop rewarding certainty and punishing skepticism. It requires the basic humility to say: “We might not know what’s going on yet, and that means we don’t get to make irreversible bets with children.”

If we don’t change course, the end state is predictable. More kids will be swept into an identity pipeline that confers instant meaning but demands escalating commitment. More parents will be coerced by policy and stigma rather than persuaded by evidence. More clinicians will practice defensively in a moralized climate. And the backlash won’t stay polite or surgical; it will arrive as a blunt instrument, because careful critics were dismissed as hateful for too long. That’s the social damage: not merely the trend itself, but the institutional refusal to admit uncertainty until the human costs become impossible to ignore.